Apr 3, 2025 · Should You Buy or Sell Inspyr Therapeutics Stock? Get The Latest NSPX Stock Analysis, Price Target, and Headlines at MarketBeat.

Inspyr Therapeutics, Inc. is a biotechnology company which focuses on the discovery and development of prodrug cancer therapeutics for the treatment of solid tumors, including liver, brain, prostate, and other cancers primarily in the United States. Its product candidates include Mipsagargin, G-115,...

Rebus Hldgs (NSPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Feb 23, 2025 · What's going on at Inspyr Therapeutics (OTCMKTS:NSPX)? Read today's NSPX news from trusted media outlets at MarketBeat.

Oct 13, 2021 · NSPX (NSPX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

Inspyr Therapeutics, Inc. is a biotechnology company which focuses on the discovery and development of prodrug cancer therapeutics for the treatment of solid tumors, including liver, …

May 23, 2015 · Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Inspyr Therapeutics, Inc. | Other OTC: NSPX | Other OTC.

Stock analysis for Rebus Holdings Inc (NSPX:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Dec 21, 2010 · Real-time Price Updates for Inspyr Therapeutics Inc (NSPX), along with buy or sell indicators, analysis, charts, historical performance, news and more

Interactive Charts provide the most advanced and flexible platform for analyzing historical data, with over 100 customizable studies, drawing tools, custom spreads and expressions, plus a wide range of visualization tools. While logged into the site, you will see continuous streaming updates to …